184710-54-1 Usage
General Description
2-(5-(tert-butoxycarbonylamino)-6-oxo-2-phenylpyrimidin-1(6H)-yl)acetic acid is a chemical compound with the molecular formula C20H22N4O7. It is a derivative of pyrimidin-2-ylacetic acid, containing a tert-butoxycarbonylamino functional group and a phenyl ring. 2-(5-(tert-butoxycarbonylamino)-6-oxo-2-phenylpyrimidin-1(6H)-yl)acetic acid is often used in pharmaceutical research and drug development due to its potential therapeutic applications and biological activities. Its precise mechanism of action and specific medicinal uses are still being investigated, but its structure and functional groups indicate that it may have activity as a potential drug target for various diseases and conditions. Further research is needed to fully understand the properties and potential applications of 2-(5-(tert-butoxycarbonylamino)-6-oxo-2-phenylpyrimidin-1(6H)-yl)acetic acid.
Check Digit Verification of cas no
The CAS Registry Mumber 184710-54-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,4,7,1 and 0 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 184710-54:
(8*1)+(7*8)+(6*4)+(5*7)+(4*1)+(3*0)+(2*5)+(1*4)=141
141 % 10 = 1
So 184710-54-1 is a valid CAS Registry Number.
184710-54-1Relevant articles and documents
Design and synthesis of new orally active inhibitors of human neutrophil elastase
Ohmoto, Kazuyuki,Okuma, Motohiro,Yamamoto, Tetsuya,Kijima, Hideomi,Sekioka, Tomohiko,Kitagawa, Kanji,Yamamoto, Shigeki,Tanaka, Kenji,Kawabata, Kazuhito,Sakata, Atsushi,Imawaka, Haruo,Nakai, Hisao,Toda, Masaaki
, p. 1307 - 1323 (2007/10/03)
To identify new orally active inhibitors, further modification of 1 (ONO-6818) was performed. Peptidic derivatives 4b, 4c and 4n showed more potent inhibitory activity than nonpeptidic derivatives 3a-c. As a result, a series of peptidic inhibitors, 4a-s a
